ReaMetrix Closes $3.5M Series A1 To Promote Offshore Business Model

ReaMetrix Inc., a biotechnology company with dual operations in the U.S. and
India that provides assays for the life sciences industry, said it closed $3.55
million in Series A1 financing, its first institutional round.